Phospholemman and beta-adrenergic stimulation in the heart

Area of Science:

• Cardiovascular Physiology
• Molecular Cardiology
• Ion Transport

Background:

• Beta-adrenergic stimulation impacts cardiac function through signaling pathways involving phospholemman (PLM).
• PLM phosphorylation at serine 68 is known to inhibit the Na(+)/Ca(2+) exchanger (NCX1) and relieve inhibition of the Na(+)-K(+)-ATPase.
• The precise role of PLM in mediating beta-adrenergic effects on in vivo cardiac function requires further investigation.

Purpose of the Study:

• To investigate the role of phospholemman (PLM) in mediating beta-adrenergic effects on in vivo cardiac function.
• To elucidate the mechanisms by which PLM influences cardiac contractility and ion homeostasis under beta-adrenergic stimulation.

Main Methods:

• Utilized congenic PLM-knockout (KO) mice and wild-type (WT) littermates for in vivo and ex vivo studies.
• Performed echocardiography and cardiac catheterization to assess cardiac function parameters (ejection fraction, contractility, relaxation).
• Investigated isolated cardiac myocytes to analyze intracellular ion concentrations ([Na(+)](i), [Ca(2+)](i)) and Na(+)-K(+)-ATPase activity.
• Conducted dose-response studies with isoproterenol (Iso) and assessed protein interactions via co-immunoprecipitation.

Main Results:

• PLM-KO mice exhibited similar baseline ejection fraction but higher baseline contractility (+dP/dt) compared to WT.
• Isoproterenol (Iso) stimulation led to a time-dependent decline in contractility and intracellular Ca(2+) transients in WT but not in PLM-KO mice.
• Iso-induced increase in Na(+)-K(+)-ATPase alpha(1)-subunit current was observed in WT but not in PLM-KO myocytes, while alpha(2)-subunit activity was unaffected.
• PLM co-immunoprecipitated with Na(+)-K(+)-ATPase alpha(1)- and alpha(2)-subunits, independent of NCX1.

Conclusions:

• Phosphorylation of PLM by beta-adrenergic agonists results in a time-dependent reduction in cardiac inotropy.
• This reduction is primarily mediated by the relief of PLM's inhibition on the Na(+)-K(+)-ATPase, particularly under conditions of elevated intracellular sodium.
• PLM plays a critical role in regulating cardiac response to beta-adrenergic stimulation, influencing contractility through modulation of Na(+)-K(+)-ATPase activity.